Report
Valens Research

VEEV - Embedded Expectations Analysis - 2020 07 06

Veeva Systems Inc. (VEEV:USA) currently trades at a historical high relative to UAFRS-based (Uniform) earnings with an 84.4x Uniform P/E, implying bullish expectations for the firm. However, management appears concerned about Veeva Engage, their Data Cloud growth strategy, and new product launches

Specifically, management may lack confidence in their ability to sustain increases in remote meetings between pharma and doctors utilizing Veeva Engage, execute their Data Cloud growth strategy, and successfully launch MyVeeva in Q4. In addition, they may be overstating the potential of their new and existing products, the capabilities of Commercial Cloud, and the information benefits of telemedicine to doctors. Furthermore, they may lack confidence in their ability to achieve their long-term $3bn investment target, meet their revenue guidance amidst macro uncertainty, and realize increased contributions from Crossix and Physicians World
Underlying
Veeva Systems Inc Class A

Veeva Systems provides industry cloud solutions for the life sciences industry. Veeva Commercial Cloud is a suite of multichannel customer relationship management applications, a commercial data warehouse, territory allocation and alignment applications, master data management applications and customer reference and data and services. Veeva Vault is the company's suite of cloud-based, enterprise content management applications that address the content management requirements for the company's customers'commercial functions, including medical and sales and marketing, and key research and development functions, including clinical, regulatory, quality, and, when available, safety.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch